MTCH vs PPCB · P/E 13, rev $3.48B vs P/E 0.0, $3.9M cap
Match Group Inc (MTCH) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
PPCB does not have a complete income-statement cache yet.
MTCH currently screens at market cap $8.24B and trailing P/E 13.5. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the MTCH and PPCB stock pages for the full models.
Not investment advice.